1. Home
  2. PRGO vs NRIX Comparison

PRGO vs NRIX Comparison

Compare PRGO & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perrigo Company plc

PRGO

Perrigo Company plc

HOLD

Current Price

$12.27

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$16.93

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRGO
NRIX
Founded
1887
2009
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
PRGO
NRIX
Price
$12.27
$16.93
Analyst Decision
Buy
Strong Buy
Analyst Count
3
12
Target Price
$19.33
$30.50
AVG Volume (30 Days)
2.2M
921.4K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
10.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$800,000.00
$76,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.02
$48.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
99.31
52 Week Low
$9.23
$8.20
52 Week High
$28.44
$22.50

Technical Indicators

Market Signals
Indicator
PRGO
NRIX
Relative Strength Index (RSI) 61.66 55.86
Support Level $12.17 $16.02
Resistance Level $15.08 $17.58
Average True Range (ATR) 0.47 0.74
MACD 0.04 -0.02
Stochastic Oscillator 76.52 53.70

Price Performance

Historical Comparison
PRGO
NRIX

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: